Reference
[Please submit your publication]
|
Bauke AC, Sasse S, Matzat T, Klämbt C. A transcriptional network controlling glial development in the Drosophila visual system. Development (2015) 142(12) 2184-93
[
PubMed ID = 26015542
]
[
RRC reference
]
Molnar C, Casado M, López-Varea A, Cruz C, de Celis JF. Genetic annotation of gain-of-function screens using RNA interference and in situ hybridization of candidate genes in the Drosophila wing. Genetics (2012) 192(2) 741-52
[
PubMed ID = 22798488
]
[
RRC reference
]
Rauskolb C, Pan G, Reddy BV, Oh H, Irvine KD. Zyxin links fat signaling to the hippo pathway. PLoS Biol (2011) 9(6) e1000624
[
PubMed ID = 21666802
]
[
RRC reference
]
|
Off-target search result
cv : coefficient of variation
(0 mm hits / total siRNA count)
mm : mismatch
|
cv |
0mm |
1mm |
2mm |
3mm |
target transcript |
off target name |
100 |
482 |
1 |
4 |
5 |
NM_138210.1 |
CG13894-RA (CG13894), mRNA |
0.41 |
2 |
2 |
2 |
2 |
NM_143465.1 |
CG1973-RA (CG1973), mRNA |
0 |
0 |
3 |
3 |
4 |
NM_169148.3 |
CG2336-RA (CG2336), mRNA |
0 |
0 |
2 |
5 |
4 |
NM_135697.1 |
CG14945-RA, transcript variant A (CG14945), mRNA |
0 |
0 |
2 |
5 |
4 |
NM_164987.1 |
CG14945-RB, transcript variant B (CG14945), mRNA |
0 |
0 |
2 |
3 |
3 |
NM_142146.1 |
CG14860-RA (CG14860), mRNA |
0 |
0 |
1 |
11 |
14 |
NM_057685.3 |
CG11527-RA (Tig), mRNA |
0 |
0 |
1 |
5 |
2 |
NM_164863.1 |
CG31884-RB, transcript variant B (Trx-2), mRNA |
0 |
0 |
1 |
5 |
2 |
NM_078802.2 |
CG31884-RA, transcript variant A (Trx-2), mRNA |
0 |
0 |
1 |
4 |
3 |
NM_166411.1 |
CG8994-RB, transcript variant B (exu), mRNA |
0 |
0 |
1 |
4 |
3 |
NM_166410.1 |
CG8994-RA, transcript variant A (exu), mRNA |
0 |
0 |
1 |
4 |
3 |
NM_166412.1 |
CG8994-RC, transcript variant C (exu), mRNA |
0 |
0 |
1 |
4 |
2 |
NM_142397.1 |
CG14318-RA (CG14318), mRNA |
0 |
0 |
1 |
3 |
6 |
NM_142456.1 |
CG15803-RA (CG15803), mRNA |
0 |
0 |
1 |
3 |
4 |
NM_134603.1 |
CG1489-RA (Pros45), mRNA |
0 |
0 |
1 |
2 |
9 |
NM_140791.2 |
CG6897-RA (CG6897), mRNA |
0 |
0 |
1 |
2 |
4 |
NM_135332.2 |
CG7380-RA (CG7380), mRNA |
0 |
0 |
0 |
5 |
6 |
NM_139356.1 |
CG3524-RA (v(2)k05816), mRNA |
0 |
0 |
0 |
5 |
3 |
NM_140060.1 |
CG3445-RA (phol), mRNA |
0 |
0 |
0 |
4 |
12 |
NM_057531.3 |
CG6863-RA, transcript variant A (tok), mRNA |
0 |
0 |
0 |
4 |
12 |
NM_170168.1 |
CG6863-RB, transcript variant B (tok), mRNA |
0 |
0 |
0 |
4 |
8 |
NM_176734.1 |
CG33206-RA, transcript variant A (l(1)G0168), mRNA |
0 |
0 |
0 |
4 |
7 |
NM_133014.2 |
CG6269-RA (unc-4), mRNA |
0 |
0 |
0 |
4 |
6 |
NM_135753.2 |
CG9934-RA (CG9934), mRNA |
0 |
0 |
0 |
4 |
6 |
NM_176735.1 |
CG33206-RB, transcript variant B (l(1)G0168), mRNA |
0 |
0 |
0 |
4 |
6 |
NM_080327.2 |
CG3665-RA, transcript variant A (Fas2), mRNA |
0 |
0 |
0 |
4 |
5 |
NM_167005.1 |
CG3665-RC, transcript variant C (Fas2), mRNA |
0 |
0 |
0 |
4 |
5 |
NM_167376.1 |
CG7107-RD, transcript variant D (up), mRNA |
0 |
0 |
0 |
4 |
5 |
NM_167004.1 |
CG3665-RB, transcript variant B (Fas2), mRNA |
0 |
0 |
0 |
4 |
3 |
NM_080349.2 |
CG7107-RA, transcript variant A (up), mRNA |
|